Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0,11%
1.095,02
+1,21
+0,11%
—1.093,811.096,521.100,221.093,20——
SIXC
Communications
SIXC
Communications
SIXC
+0,14%
609,60
+0,83
+0,14%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,24%
1.239,24
-15,57
-1,24%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,72%
1.748,50
-12,61
-0,72%
—1.761,111.764,271.766,881.745,39——
SIXM
Financials
SIXM
Financials
SIXM
-0,12%
641,82
-0,76
-0,12%
—642,58644,87648,48641,41——
SIXR
Staples
SIXR
Staples
SIXR
-0,41%
847,62
-3,51
-0,41%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,37%
217,18
-0,80
-0,37%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,45%
3.258,27
+46,44
+1,45%
—3.211,833.227,213.267,763.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,63%
942,99
-5,99
-0,63%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,20%
1.471,55
-2,97
-0,20%
—1.474,521.479,031.481,041.469,17——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,49%
2.403,80
+11,68
+0,49%
—2.392,122.396,952.421,222.382,32——
PYXS:NASDAQ
Pyxis Oncology Inc
1,72 US$
+0,88%
(+0,015) 1D
1 may, 15:03:47 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PYXS...
Açın
1,71 US$
High
1,72 US$
Low
1,67 US$
Mkt. cap
107,76 mln
Avg. vol.
356,78K
Volume
55,29K
52-wk high
5,55 US$
52-wk low
0,97 US$
EPS
-1,28 US$
Beta
1,41
Shares outstanding
62,83 mln
No. of employees
56
News stories
From sources across the web
About Pyxis Oncology Inc
CEO-
Employees56
Founded2018
HeadquartersBoston, Massaçusets, Amerika Birləşmiş Ştatları
Sector-
Websitepyxisoncology.com
Next call 12 gün ərzində
13 may, Ç., 12:30
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ (-0,36 est.)USD
Revenue / Estimate
-/ (0,00 est.)USD
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earningsInsights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
-
2,82 mln
-
11,04 mln
Cost of goods sold
-
-
-
2,39 mln
Cost of revenue
-
-
-
2,39 mln
Research and development expenses
17,04 mln
17,13 mln
17,81 mln
21,71 mln
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,36 mln
4,75 mln
4,97 mln
4,54 mln
Operating expense
22,40 mln
21,89 mln
22,78 mln
26,25 mln
Total operating expenses
22,40 mln
21,89 mln
22,78 mln
28,64 mln
Operating income
-22,40 mln
-19,07 mln
-22,78 mln
-17,60 mln
Other non operating income
-
-
-
-
EBT including unusual items
-21,16 mln
-18,07 mln
-22,00 mln
-17,00 mln
EBT excluding unusual items
-21,16 mln
-18,07 mln
-22,00 mln
-17,00 mln
Income tax expense
-
283,00K
-
1,10 mln
Effective tax rate
-
-1,57%
-
-6,49%
Other operating expenses
-
-
-
-
Net income
-21,16 mln
-18,35 mln
-22,00 mln
-18,11 mln
Net profit margin
-
-650,85%
-
-164,03%
Earnings per share
-0,35
-0,30
-0,35
-0,29
Interest and investment income
1,24 mln
995,00K
774,00K
600,00K
Interest expense
-
-
-
-
Net interest expenses
1,24 mln
995,00K
774,00K
600,00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,85 mln
-18,53 mln
-22,25 mln
-14,71 mln
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer